Trials / Conditions / Idiopathic Retroperitoneal Fibrosis

Idiopathic Retroperitoneal Fibrosis

6 registered clinical trials studyying Idiopathic Retroperitoneal Fibrosis — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fib NCT05428826	Assistance Publique - Hôpitaux de Paris	Phase 4
Unknown	A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis NCT04762784	Peking Union Medical College Hospital	Phase 4
Recruiting	National Registry of IRPF in China NCT04314323	Peking Union Medical College Hospital	—
Recruiting	A Prospective Cohort Study of IRPF in China NCT04312854	Peking Union Medical College Hospital	—
Unknown	A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis NCT04762810	Peking Union Medical College Hospital	Phase 4
Unknown	Methotrexate as a Steroid-sparing Agent in Idiopathic Retroperitoneal Fibrosis: a Randomised, Multicenter Tria NCT01240850	University of Parma	Phase 3